MMasters in Business
← All episodes
Charles Strom17 June 2022

Charles Strom on the Diagnostics Industry

2Frameworks
13Insights

Listen

Frameworks in this episode

Insights & moments

The myth-busts, hot takes, explainers, and tools worth keeping.

Myth Buster· 1

Myth Buster35:45

Why Preventive Testing Is Not Always in an Insurer's Interest

Although early testing can reduce long-term healthcare costs, insurers may not capture the future savings because members frequently change plans. Strom says quarterly pressures and fragmented coverage can encourage short-term decisions even when prevention would benefit the healthcare system overall.

  • Members often change insurers within a few years
  • The insurer paying for prevention may not receive the later savings
  • Public companies face quarterly earnings pressure
  • Professional recommendations do not guarantee coverage
  • Fragmentation blocks a uniform preventive-testing strategy

“why should I do this task if it's going to prevent a heart attack in a patient five or ten years down the line”

Charles Strom · 36:42

“sometimes they make short sighted decisions.”

Charles Strom · 37:29
#health insurance#preventive care#incentives#reimbursement

Hot Take· 2

Hot Take22:57

The Missing Study Behind Personalized Booster Decisions

Strom argues that repeated quantitative antibody testing across a population could connect antibody levels with infection, hospitalization, long COVID, and death. He stresses that current evidence does not yet justify firm personal recommendations, but the data could reveal who responds poorly to particular vaccines.

  • Track antibody levels repeatedly across a large population
  • Follow infections and clinical outcomes over time
  • Correlate outcomes with antibody concentration and affinity
  • Use the results to investigate individualized vaccine responses
  • Current data remain insufficient for definitive recommendations

“this is the kind of data that we need.”

Charles Strom · 23:17

“everybody is not the same.”

Charles Strom · 25:22
#public health#boosters#antibody research#covid-19
Hot Take56:25

Your Insurance Plan Can Decide Which Medical Test You Receive

Strom argues that insurance coverage shapes medical care more directly than many patients realize, including which laboratories and testing technologies clinicians can use. Consumers tend to compare premiums and copays during enrollment but cannot reasonably predict every future diagnostic need.

  • Insurers can restrict both tests and laboratories
  • Patients with different coverage may receive different testing technologies
  • Coverage limitations often become visible only after serious illness
  • Healthcare choices are too complex for conventional informed-consumer assumptions

“your insurance company decides what tests your doctor can order and from what laboratory.”

Charles Strom · 56:54

“the paradigm of, you know, an informed consumer in a capitalist system with free enterprise, I think doesn't work very well for healthcare.”

Charles Strom · 58:31
#insurance#patient access#healthcare economics

Explainer· 2

Explainer12:25

How Saliva Could Help Resolve Suspicious Lung Nodules

Liquid Diagnostics' open platform detected circulating tumor DNA in patients with early-stage lung cancer. Strom describes an NIH-funded study testing whether saliva, plasma, or both can help determine which indeterminate CT nodules warrant biopsy.

  • Most lung cancer is diagnosed after curative treatment is unlikely
  • Spiral CT scans often reveal nodules whose status is uncertain
  • The platform detected circulating tumor DNA in early-stage disease
  • The study aims to reduce unnecessary biopsies while identifying dangerous nodules

“he could UH detect circulating tumor DNA in patients with early stage lung cancer, something that had never been done before successfully.”

Charles Strom · 12:51

“to see if we can inform the decision about who needs a biopsy UH and who doesn't need a biopsy”

Charles Strom · 16:28
#lung cancer#liquid biopsy#saliva diagnostics#early detection
Explainer18:38

What Quantitative COVID Antibody Results Add

Unlike qualitative home tests or semi-quantitative laboratory reports, Liquid Diagnostics' saliva assay reports an antibody concentration and compares it with a vaccinated reference population. Repeated noninvasive testing can show how an individual's levels change over time.

  • PCR detects the virus rather than antibodies
  • Home antibody tests generally report only positive or negative
  • A concentration becomes more meaningful when paired with a population percentile
  • Saliva collection enables repeated longitudinal measurements

“Our test actually gives you the level of your antibody”

Charles Strom · 20:06

“Then we tell you you're in the eightieth percentile for all patients who have been vaccinated against COVID”

Charles Strom · 20:26
#covid-19#antibodies#saliva testing#personalized medicine

Story· 3

Story07:50

The Murder Case That Helped Establish Forensic DNA in Illinois

Before forensic DNA was routinely admitted in Illinois courts, prosecutors asked Strom to assist with difficult cases. In one case, DNA evidence identified a murdered woman from remains burned in a steel drum, and the evidence survived the admissibility process.

  • Forensic DNA was not yet routinely admitted in Illinois
  • Scientific evidence had to pass a Frye hearing
  • The victim's identity was established from severely burned remains
  • The DNA evidence contributed to the murder conviction

“We were able to actually to identify his wife from the charred remains in UH the steel drum.”

Charles Strom · 09:49

“the pry evidence was accepted and he was convicted.”

Charles Strom · 09:57
#forensic dna#legal evidence#genetics
Story44:18

The Heel Stick That Can Transform a Child's Life

Strom calls newborn screening an underappreciated system for finding rare metabolic diseases before irreversible damage occurs. He describes children who avoided devastating neurological outcomes because screening led quickly to specialized diets and treatment.

  • California screens newborns for roughly fifty inherited metabolic disorders
  • Early identification connects children with specialist care
  • Some severe metabolic diseases can be controlled through diet
  • Legislative mandates also secure coverage for follow-up care

“Newborn screening is one of the most amazing phenomenon for disease identification and early treatment that nobody knows about.”

Charles Strom · 44:18

“is now three years old and completely normal.”

Charles Strom · 45:25
#newborn screening#rare disease#pediatrics#early treatment
Story46:10

Sequencing Found a Treatable Disorder Behind a Cerebral Palsy Diagnosis

An eighteen-month-old child with hypotonia and spastic movements had been diagnosed with cerebral palsy. Whole-exome sequencing instead revealed a treatable inherited metabolic disorder, and the child began improving after targeted treatment.

  • The child's symptoms had been attributed to cerebral palsy
  • Whole-exome sequencing compared genes across the child and parents
  • Testing identified a specific inherited metabolic disorder
  • A molecular diagnosis changed treatment and prognosis

“It turned out he had a treatable inborn error metabolism”

Charles Strom · 46:38

“we started to treat him and he's getting better.”

Charles Strom · 46:43
#whole exome sequencing#rare disease#misdiagnosis#genetic medicine

Tool· 1

Tool29:42

A Two-Minute Saliva Collection Instead of a Blood Draw

The saliva test uses a plastic wand with a sponge held between the cheek and gums for two minutes. Collection can occur at home or in an office, after which the sample can be mailed in appropriate biohazard packaging.

  • No blood draw is required
  • Collection takes about two minutes
  • Samples can be collected in multiple settings
  • Mail-in processing supports repeated testing
  • The underlying assay cost is comparable to a blood test without phlebotomy costs

“You just put plastic wand with a sponge on the end of it into your mouth between your cheek and gums for two minutes.”

Charles Strom · 30:08

“then it can be mailed in using the appropriate biohazard containers.”

Charles Strom · 30:23
#saliva test#diagnostics#sample collection

Takeaway· 4

Takeaway06:47

Why Strom Chose Applied Science Over Basic Research

Strom distinguishes basic scientists who investigate a narrow problem deeply from applied scientists who ask how discoveries can help people. His career focused on translating laboratory knowledge into medical and forensic practice.

  • Basic science pursues deep understanding of a specific problem
  • Applied science emphasizes practical human benefit
  • Modern medicine calls this translational medicine
  • Strom used academic freedom to bring DNA testing into forensic cases

“I've always been what I call an applied scientist.”

Charles Strom · 06:47

“how are we going to take what we learned at the lab bench and put it into practice?”

Charles Strom · 07:40
#applied science#translational medicine#genetics
Takeaway1:01:30

Distrust the Experiment That Gives You Exactly What You Expected

Strom recalls mentor Albert Dorfman's warning that expected results deserve special skepticism. Discovery often comes from anomalies and accidents, yet modern science's project-managed structure can leave too little room for investigating the unexpected.

  • Expected findings may reflect confirmation bias
  • Unexpected observations can reveal new mechanisms
  • Fleming's accidental discovery of penicillin illustrates the point
  • Rigidly managed research can discourage anomaly-driven discovery

“when I designed an experiment and I think I know what the results should be, and I get that result, I don't trust it.”

Charles Strom · 1:01:49

“science and discovery is about what you're not expecting.”

Charles Strom · 1:02:03
#scientific method#discovery#confirmation bias#research
Takeaway1:05:54

Why Future Geneticists Must Understand Algorithms

As sequencing becomes routine, Strom says the core challenge is interpreting the enormous volume of resulting data. Medical professionals need enough informatics literacy to understand algorithmic strengths, weaknesses, and blind alleys rather than surrendering judgment to technical specialists.

  • Next-generation sequencing has reduced the relative importance of wet-lab work
  • Data interpretation is now a central genetics skill
  • Computer specialists may lack clinical context
  • Clinicians must recognize algorithmic assumptions and weaknesses
  • Large datasets can support valuable medical prediction

“you have to get a handle on the informatics.”

Charles Strom · 1:06:44

“you need to know where the weaknesses are in the computer algorithms or else you're going to start, you know, being let off on blind…”

Charles Strom · 1:07:00
#bioinformatics#genetics careers#algorithms#medical data
Takeaway1:09:10

How Reimbursement Rules Reshape Medical Practice

Strom uses Medicare diagnostic-related groups and procedure reimbursement to illustrate how policy changes alter institutional behavior, specialty power, and career economics. Even scheduling software can transform clinical work by imposing standardized appointment lengths that conflict with complex care.

  • Payment by diagnosis changed hospital incentives
  • Higher procedural reimbursement strengthened procedure-heavy specialties
  • Later adjustments shifted incentives toward primary care
  • Standardized scheduling can undermine complex specialist visits
  • Medical legislation frequently produces second-order effects

“one of the most important things that I've learned is unintended consequences.”

Charles Strom · 1:09:10

“be careful when you legislate anything that has to do with medicine.”

Charles Strom · 1:11:08
#health policy#reimbursement#unintended consequences#medical practice